Cure Ventures Revenue and Competitors
Employee Data
- Cure Ventures has 17 Employees.
- Cure Ventures grew their employee count by 55% last year.
Cure Ventures's People
Name | Title | Email/Phone |
---|---|---|
1 | Partner and Chief Financial Officer | Reveal Email/Phone |
2 | Chief Technology Officer, Partner | Reveal Email/Phone |
3 | Partner | Reveal Email/Phone |
4 | Partner | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
6 | Executive Assistant | Reveal Email/Phone |
7 | Partner | Reveal Email/Phone |
8 | Associate | Reveal Email/Phone |
9 | Venture Partner | Reveal Email/Phone |
10 | Managing Partner | Reveal Email/Phone |
Cure Ventures Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 30 | -60% | N/A | N/A |
#2 | N/A | 44 | 38% | N/A | N/A |
#3 | $7.5M | 36 | 20% | N/A | N/A |
#4 | $7.5M | 103 | 21% | N/A | N/A |
#5 | N/A | 69 | 138% | N/A | N/A |
#6 | N/A | 55 | 817% | N/A | N/A |
#7 | $3.5M | 32 | -9% | N/A | N/A |
#8 | $15M | 168 | 11% | N/A | N/A |
#9 | $3.5M | 158 | 6% | N/A | N/A |
#10 | N/A | 17 | 55% | N/A | N/A |
What Is Cure Ventures?
Cure Ventures is a venture capital firm focusing on company formation around groundbreaking curative technologies.\n\nCure Ventures harnesses our team's skills and decades of company-building experience to create innovative companies that aim to eradicate diseases by focusing on de novo company formation built around bold ideas and visionary entrepreneurs. \n\nWe provide the right level of human and financial capital that is required at each stage of the company's life. We seek to build great companies around pioneering scientific solutions with strong intellectual property positions. The Cure Ventures team focuses on disruptive technologies that target high unmet patient needs.\n\nThe optimal company build will exhibit a clear genetic validation, substantiated and rigorously derived scientific data, the provenance of a distinguished scientific laboratory, biology with mechanistic clarity, multiple commercial applications, large uncrowded markets, expedited clinical routes, string partnering interest from large pharmaceutical companies, and an articulable oath to an exit.
keywords:N/AN/A
Total Funding
17
Number of Employees
N/A
Revenue (est)
55%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 17 | -53% | N/A |
#2 | $1.5M | 17 | -6% | N/A |
#3 | $1.5M | 17 | -11% | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |